Walgreens (WBA, $54.66) tops fiscal Q2 earnings and sales estimates
Walgreens Boots Alliance’s fiscal third-quarter earnings surpassed analysts’ estimates, as the pharmacy retail giant bounced back with strong prescription drug sales.
Walgreens reported adjusted earnings of $1.47 a share for the quarter ended May 31, compared to analysts’ expectations of $1.43.
Revenue of $34.59 billion also came in higher than analysts’ estimates of $34.46 billion. Sales in the quarter rose +0.7% from a year earlier, (or 2.9% after adjusting for fluctuations in currency rates). Walgreens mentioned its U.S. retail pharmacy business and pharmaceutical wholesale business as key drivers of growth.
U.S. pharma sales rose 4.3% while comparable sales rose 6%, according to Walgreens. Three analysts polled by Refinitiv had expected a 2.9% rise in same-store sales.
CEO Stefano Pessina emphasized that after a challenging second quarter, Walgreen has been able to improve its performance in the third quarter and has progressed in line with the goals set.
WBA sees MACD Histogram just turned negative
WBA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 26, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for WBA moved out of overbought territory on August 22, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on WBA as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WBA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WBA advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 132 cases where WBA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Advertisement
General Information
a provider of drug store services
Industry DrugstoreChains
Advertisement